Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel Blueprint Genetics Finland | 2 | 308 |
|
Comprehensive Skeletal Dysplasias and Disorders Panel Blueprint Genetics Finland | 1 | 246 |
|
Skeletal Dysplasias Core Panel Blueprint Genetics Finland | 1 | 111 |
|
OSTEOPETROSIS, AUTOSOMAL DOMINANT (ALBERS-SCHONBERG DISEASE) Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
OSTEOPETROSIS, AUTOSOMAL RECESSIVE Laboratorio de Genetica Clinica SL Spain | 8 | 8 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Primary Immunodeficiency Panel Blueprint Genetics Finland | 2 | 275 |
|
Osteopetrosis and Dense Bone Dysplasia Panel Blueprint Genetics Finland | 1 | 25 |
|
Comprehensive Hematology Panel Blueprint Genetics Finland | 4 | 239 |
|
Blueprint Genetics Finland | 2 | 78 |
|
Skeletal dysplasia with increased bone density Panel CeGaT GmbH Germany | 26 | 28 |
|
Autosomal recessive osteopetrosis type 4 Bioarray Spain | 1 | 1 |
|
Osteopetrosis autosomal dominant type 2 Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 557 | 182 |
|
Fulgent Genetics United States | 5130 | 4674 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Baylor Genetics United States | 842 | 637 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.